Cytotoxic activity of aeroplysinin-1 against colon cancer cells by promoting β-catenin degradation

An aberrant accumulation of beta-catenin in intestinal epithelial cells is relevant to the development and progression of colon cancer and is thus a potential target for the development of therapeutics for this malignancy. Here, we used cell-based natural compound screening with genetically engineered HEK293 reporter cells to identify aeroplysinin-1, a brominated tyrosine derivative originated from marine sponges, as an inhibitor of Wnt/beta-catenin signaling. Aeroplysinin-1 suppressed the beta-catenin response transcription that was activated by Wnt3a-conditioned medium or 6-bromoindirubin-3'-oxime (an inhibitor of glycogen synthase kinase-3 beta) by promoting the proteasomal degradation of intracellular beta-catenin. Consistently, aeroplysinin-1 decreased the amount of intracellular beta-catenin and repressed the expression of beta-catenin/T-cell factor-dependent genes, thereby inhibiting the proliferation of colon cancer cells. In addition, apoptosis was elicited by aeroplysinin-1, as indicated by the increase in the population of Annexin V-FITC stained cells and caspase-3/7 activities in DLD-1 colon cancer cells. These findings indicate that aeroplysinin-1 exerts its antiproliferative activity by attenuating Wnt/beta-catenin signaling and may have potential as a chemopreventive agent for human colon cancer. (C) 2016 Elsevier Ltd. All rights reserved.